ImmunityBio, Inc. (IBRX)
USD 2.42
(-11.03%)
USD 2.42
(-11.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -583.19 Million USD | -39.75% |
| 2022 | -417.32 Million USD | -19.29% |
| 2021 | -349.84 Million USD | -56.05% |
| 2020 | -224.18 Million USD | -39.98% |
| 2019 | -160.15 Million USD | -66.44% |
| 2018 | -96.22 Million USD | 0.2% |
| 2017 | -96.42 Million USD | 20.19% |
| 2016 | -120.8 Million USD | 49.0% |
| 2015 | -236.87 Million USD | -3712.59% |
| 2014 | -6.21 Million USD | 0.0% |
| 2013 | -2.04 Million USD | N/A |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -134.1 Million USD | 42.54% |
| 2024 Q2 | -134.56 Million USD | -0.34% |
| 2023 Q3 | -95.58 Million USD | 30.68% |
| 2023 Q4 | -233.39 Million USD | -144.18% |
| 2023 FY | -583.19 Million USD | -39.75% |
| 2023 Q1 | -151.16 Million USD | -39.54% |
| 2023 Q2 | -137.87 Million USD | 8.79% |
| 2022 Q4 | -108.32 Million USD | 2.35% |
| 2022 FY | -417.32 Million USD | -19.29% |
| 2022 Q1 | -102.82 Million USD | -12.67% |
| 2022 Q2 | -94.58 Million USD | 8.01% |
| 2022 Q3 | -110.93 Million USD | -17.29% |
| 2021 FY | -349.84 Million USD | -56.05% |
| 2021 Q3 | -87.62 Million USD | 0.75% |
| 2021 Q4 | -91.25 Million USD | -4.14% |
| 2021 Q1 | -79.61 Million USD | -17.48% |
| 2021 Q2 | -88.28 Million USD | -10.9% |
| 2020 FY | -224.18 Million USD | -39.98% |
| 2020 Q3 | -65.6 Million USD | -27.54% |
| 2020 Q4 | -67.77 Million USD | -3.3% |
| 2020 Q2 | -51.43 Million USD | -38.88% |
| 2020 Q1 | -37.03 Million USD | -66.27% |
| 2019 Q4 | -22.27 Million USD | -42.92% |
| 2019 FY | -160.15 Million USD | -66.44% |
| 2019 Q2 | -16.68 Million USD | 6.73% |
| 2019 Q1 | -17.88 Million USD | -3.14% |
| 2019 Q3 | -15.58 Million USD | 6.57% |
| 2018 Q4 | -17.34 Million USD | 26.63% |
| 2018 FY | -96.22 Million USD | 0.2% |
| 2018 Q1 | -27.51 Million USD | -12.38% |
| 2018 Q3 | -23.63 Million USD | 14.77% |
| 2018 Q2 | -27.73 Million USD | -0.77% |
| 2017 Q2 | -23.45 Million USD | 4.34% |
| 2017 Q4 | -24.48 Million USD | -2.16% |
| 2017 FY | -96.42 Million USD | 20.19% |
| 2017 Q1 | -24.51 Million USD | -1.14% |
| 2017 Q3 | -23.96 Million USD | -2.2% |
| 2016 Q1 | -30.65 Million USD | 60.1% |
| 2016 Q4 | -24.23 Million USD | 24.01% |
| 2016 FY | -120.8 Million USD | 49.0% |
| 2016 Q3 | -31.89 Million USD | 6.18% |
| 2016 Q2 | -33.99 Million USD | -10.92% |
| 2015 Q4 | -76.82 Million USD | -80.12% |
| 2015 Q2 | -84.58 Million USD | 0.0% |
| 2015 FY | -236.87 Million USD | -3712.59% |
| 2015 Q3 | -42.64 Million USD | 49.58% |
| 2014 FY | -6.21 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1023.151% |
| Jaguar Health, Inc. | -41.3 Million USD | -1312.097% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -281.194% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -971.618% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -32.472% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1218.219% |
| ContextLogic Inc. | -317 Million USD | -83.974% |
| MiMedx Group, Inc. | 67.43 Million USD | 964.776% |
| MEI Pharma, Inc. | 17.77 Million USD | 3380.436% |
| AlloVir, Inc. | -190.41 Million USD | -206.271% |
| Novavax, Inc. | -545.06 Million USD | -6.996% |
| Aptorum Group Limited | -2.82 Million USD | -20546.686% |
| Ardelyx, Inc. | -66.06 Million USD | -782.734% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -184.105% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1039.966% |
| Vaxcyte, Inc. | -402.26 Million USD | -44.978% |
| Precigen, Inc. | -95.9 Million USD | -508.104% |
| Pharming Group N.V. | -10.54 Million USD | -5428.972% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -189.295% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2276.221% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2224.323% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -174.807% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3044.576% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2296.109% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2296.109% |
| Bicycle Therapeutics plc | -180.66 Million USD | -222.807% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -126.193% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2041.112% |
| Acelyrin, Inc. | -381.64 Million USD | -52.813% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1461.853% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1610.202% |
| Senti Biosciences, Inc. | -92.91 Million USD | -527.639% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -457.022% |
| AbCellera Biologics Inc. | -146.39 Million USD | -298.363% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1559.636% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -225.711% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -8623.949% |
| Chimerix, Inc. | -82.09 Million USD | -610.392% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1886.227% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2774.161% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1207.517% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1042.223% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1176.028% |
| Alkermes plc | 355.75 Million USD | 263.931% |
| Fortress Biotech, Inc. | -60.63 Million USD | -861.782% |
| Fortress Biotech, Inc. | -60.63 Million USD | -861.782% |
| Agenus Inc. | -245.76 Million USD | -137.302% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -614.876% |
| Dyadic International, Inc. | -6.79 Million USD | -8482.14% |
| ImmuCell Corporation | -5.77 Million USD | -9999.335% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -62207.265% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -416.281% |
| Lantern Pharma Inc. | -15.96 Million USD | -3553.759% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3680.592% |
| Incyte Corporation | 597.59 Million USD | 197.59% |
| IO Biotech, Inc. | -86.08 Million USD | -577.481% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -900.456% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2964.794% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -888.758% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -254.367% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6760.322% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -695.119% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -56.089% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -1.807% |
| NextCure, Inc. | -62.72 Million USD | -829.796% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5740.136% |
| Onconetix, Inc. | -37.4 Million USD | -1458.944% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1377.231% |
| Opthea Limited | -220.24 Million USD | -164.798% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1258.095% |
| PureTech Health plc | -65.69 Million USD | -787.706% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -690.346% |
| Seer, Inc. | -86.27 Million USD | -575.958% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4649588.384% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1695.278% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4361.46% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1949.754% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -914.025% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -836.786% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -340.171% |
| ChromaDex Corporation | -4.93 Million USD | -11710.369% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -16154.069% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -471.369% |
| CRISPR Therapeutics AG | -153.61 Million USD | -279.66% |
| Precision BioSciences, Inc. | -61.31 Million USD | -851.085% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -262.396% |
| Innoviva, Inc. | 179.72 Million USD | 424.499% |
| Summit Therapeutics Inc. | -614.92 Million USD | 5.16% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -770.507% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -786.788% |
| ESSA Pharma Inc. | -26.58 Million USD | -2093.922% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1480.502% |
| GT Biopharma, Inc. | -7.59 Million USD | -7576.662% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -141.628% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 916.687% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1087.288% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5762.594% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -137.462% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1038.899% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -493.294% |
| Soligenix, Inc. | -6.14 Million USD | -9397.177% |
| Century Therapeutics, Inc. | -136.67 Million USD | -326.709% |
| Kura Oncology, Inc. | -152.63 Million USD | -282.095% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -553.675% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5434.219% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 103234.737% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -102394.903% |
| Autolus Therapeutics plc | -208.38 Million USD | -179.867% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -711.144% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -723.781% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2591.508% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -158.911% |
| GRI Bio, Inc. | -13.03 Million USD | -4373.391% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -14005.333% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -370.001% |
| IGM Biosciences, Inc. | -246.41 Million USD | -136.671% |
| INmune Bio, Inc. | -30 Million USD | -1843.468% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -427.498% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1282.185% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3553.731% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3592.286% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -877.123% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -476.469% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -111.206% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -145.152% |
| Verastem, Inc. | -87.36 Million USD | -567.524% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -976.246% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -261.479% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -399.919% |
| Histogen Inc. | -10.62 Million USD | -5390.971% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3982.074% |
| Surrozen, Inc. | -43.04 Million USD | -1254.946% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3875.162% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11364.373% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1014.267% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2208.499% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2064.957% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6878.461% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -286.005% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1091.995% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1861.971% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5498.124% |
| Apollomics, Inc. | -172.6 Million USD | -237.887% |
| Amarin Corporation plc | -59.11 Million USD | -886.595% |
| Mesoblast Limited | -87.95 Million USD | -563.054% |
| Turnstone Biologics Corp. | -55.2 Million USD | -956.514% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -296.835% |
| Synaptogenix, Inc. | -6.03 Million USD | -9557.955% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3498.198% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -647.496% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12071.557% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6840.995% |
| Exelixis, Inc. | 207.76 Million USD | 380.7% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1366.791% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -305.144% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -10.323% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4691.28% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7381.965% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1796.634% |
| Gritstone bio, Inc. | -138.49 Million USD | -321.111% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -804.671% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -14480.082% |
| Avid Bioservices, Inc. | -140.75 Million USD | -314.34% |
| Insmed Incorporated | -749.56 Million USD | 22.196% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3739.466% |
| MediWound Ltd. | -6.71 Million USD | -8583.681% |
| OmniAb, Inc. | -50.61 Million USD | -1052.129% |
| Alector, Inc. | -130.39 Million USD | -347.267% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -412.817% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1024.84% |
| Zai Lab Limited | -334.62 Million USD | -74.286% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -80.007% |
| Aura Biosciences, Inc. | -76.4 Million USD | -663.266% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -148.558% |
| Immunic, Inc. | -93.61 Million USD | -522.993% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -329.158% |
| Veracyte, Inc. | -74.4 Million USD | -683.823% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7498.1% |
| FibroGen, Inc. | -284.23 Million USD | -105.183% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2123.224% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8229.123% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2996.721% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 240.586% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2485.662% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1283.65% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4702.241% |
| Galecto, Inc. | -38.34 Million USD | -1420.759% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2991.254% |
| Fortrea Holdings Inc. | -3.4 Million USD | -17052.824% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -360.5% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3249.584% |
| XBiotech Inc. | -24.55 Million USD | -2274.867% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -804.671% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -830.434% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -492.522% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2621.781% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -956.648% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 3.864% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -754.437% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1024236.952% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -157.437% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2519.043% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -165.439% |
| NexImmune, Inc. | -32.34 Million USD | -1703.082% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -10931.644% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4052.074% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 114.751% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2307.811% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4923.296% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -399.32% |
| Ainos, Inc. | -13.77 Million USD | -4135.096% |
| Pluri Inc. | -20.88 Million USD | -2692.015% |
| Prothena Corporation plc | -147.02 Million USD | -296.656% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -412.155% |
| Celularity Inc. | -196.29 Million USD | -197.102% |
| Rallybio Corporation | -74.56 Million USD | -682.142% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1049.54% |
| MeiraGTx Holdings plc | -84.02 Million USD | -594.058% |
| Omeros Corporation | -117.81 Million USD | -395.018% |
| Humacyte, Inc. | -110.77 Million USD | -426.464% |
| Immunocore Holdings plc | -55.28 Million USD | -954.852% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3142.86% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2443.265% |
| Blueprint Medicines Corporation | -506.98 Million USD | -15.032% |
| CalciMedica, Inc. | -34.35 Million USD | -1597.459% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -761.76% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -312.43% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -251.77% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -105.891% |
| Pulmatrix, Inc. | -14.12 Million USD | -4029.991% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1557.042% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -605.724% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -21.198% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -456.108% |
| Cytokinetics, Incorporated | -526.24 Million USD | -10.822% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1517.069% |
| Nutriband Inc. | -5.48 Million USD | -10531.953% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1342.84% |
| Vor Biopharma Inc. | -117.86 Million USD | -394.808% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 113.41% |
| Evogene Ltd. | -23.87 Million USD | -2342.297% |
| ProKidney Corp. | -35.46 Million USD | -1544.288% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -386.958% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7333.614% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 9.329% |
| CorMedix Inc. | -46.33 Million USD | -1158.536% |
| BioLineRx Ltd. | -60.61 Million USD | -862.147% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -473.199% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1320.143% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1349.871% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -623.118% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -672.23% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -99.594% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1992.108% |
| MediciNova, Inc. | -8.57 Million USD | -6703.884% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -373.078% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6862.01% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2145.933% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -143.772% |
| Biomea Fusion, Inc. | -117.25 Million USD | -397.374% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 6.928% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1879.217% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -280.771% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -178.561% |
| Absci Corporation | -110.56 Million USD | -427.464% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1834.315% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -478.355% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -147.183% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4240.841% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -202.234% |
| Allakos Inc. | -185.7 Million USD | -214.051% |
| Imunon, Inc. | -19.51 Million USD | -2888.453% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -499.164% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 649.459% |
| BioAtla, Inc. | -123.46 Million USD | -372.369% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4691.28% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3527.292% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -78.203% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1478.381% |
| XOMA Corporation | -40.83 Million USD | -1328.317% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -472.49% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -392.095% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1057.388% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -565.149% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -284.291% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -145.315% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1560.628% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7107.122% |
| Akari Therapeutics, Plc | -10 Million USD | -5727.298% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -866139.881% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 307.105% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8650.26% |
| UroGen Pharma Ltd. | -102.24 Million USD | -470.396% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -446.099% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7398.807% |
| Orgenesis Inc. | -55.36 Million USD | -953.442% |
| Entera Bio Ltd. | -8.88 Million USD | -6460.873% |
| GH Research PLC | -35.58 Million USD | -1538.789% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2698.445% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -653.6% |
| Xencor, Inc. | -126.08 Million USD | -362.535% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -15387.046% |
| Replimune Group, Inc. | -215.79 Million USD | -170.256% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2642.318% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 23344.161% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8650.26% |
| Portage Biotech Inc. | -75.33 Million USD | -674.096% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6862.01% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -503.379% |
| OncoCyte Corporation | -27.78 Million USD | -1999.262% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4246.626% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5143.852% |
| Purple Biotech Ltd. | -19.88 Million USD | -2833.581% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8208.819% |
| scPharmaceuticals Inc. | -54.81 Million USD | -964.032% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3231.379% |
| HilleVax, Inc. | -123.56 Million USD | -371.971% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5670.219% |
| Tharimmune, Inc. | -9.31 Million USD | -6158.076% |
| Genprex, Inc. | -30.86 Million USD | -1789.784% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -147.196% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1837.915% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -32627.048% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -10911.978% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3466051.891% |
| Savara Inc. | -54.69 Million USD | -966.211% |
| Curis, Inc. | -47.41 Million USD | -1130.034% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1833.585% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3675.932% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -10372.185% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1856.049% |
| BeiGene, Ltd. | -881.7 Million USD | 33.856% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2638.781% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -33.648% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -638.644% |
| Erasca, Inc. | -125.04 Million USD | -366.4% |
| bluebird bio, Inc. | -211.91 Million USD | -175.205% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -11562.761% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 447.876% |
| DBV Technologies S.A. | -72.72 Million USD | -701.909% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -11562.761% |
| Moderna, Inc. | -4.71 Billion USD | 87.628% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1352.29% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -10142.29% |
| Molecular Templates, Inc. | -8.12 Million USD | -7078.68% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -865.748% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -423.52% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -330.874% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1117.045% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -312.36% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -203.101% |
| MacroGenics, Inc. | -9.05 Million USD | -6338.463% |
| RenovoRx, Inc. | -10.23 Million USD | -5599.726% |
| Adicet Bio, Inc. | -142.65 Million USD | -308.807% |
| Prime Medicine, Inc. | -198.13 Million USD | -194.346% |
| Aditxt, Inc. | -32.38 Million USD | -1701.053% |
| Adagene Inc. | -18.94 Million USD | -2978.141% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7876.177% |
| Quantum-Si incorporated | -95.96 Million USD | -507.749% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -389.961% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3900.585% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 540.713% |
| SciSparc Ltd. | -5.12 Million USD | -11286.099% |
| Vericel Corporation | -3.18 Million USD | -18227.97% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -484870.147% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1843.64% |
| Generation Bio Co. | -126.61 Million USD | -360.617% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -700.093% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -607.402% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -122.475% |
| Invivyd, Inc. | -198.64 Million USD | -193.59% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -70.539% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6613.764% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2657.204% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5806.38% |
| 2seventy bio, Inc. | -217.57 Million USD | -168.05% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1965.215% |
| Clene Inc. | -49.5 Million USD | -1078.079% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2516.691% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1079.747% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2145.933% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -77.768% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1692.083% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2666.884% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -490.329% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -680.154% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -262.673% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 5.181% |
| Evaxion Biotech A/S | -22.12 Million USD | -2535.914% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -622.349% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -191.499% |
| Trevena, Inc. | -40.28 Million USD | -1347.532% |
| Surrozen, Inc. | -43.04 Million USD | -1254.946% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -743.573% |
| Cingulate Inc. | -23.53 Million USD | -2378.0% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8337.442% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1363.111% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -7463.49% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -546.487% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -851.597% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -880.112% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4778.247% |
| Kronos Bio, Inc. | -112.67 Million USD | -417.6% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -742.805% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -22994502.225% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -578.964% |
| Statera Biopharma, Inc. | -174.4 Million USD | -234.386% |
| Korro Bio, Inc. | -81.17 Million USD | -618.469% |
| Kineta, Inc. | -14.09 Million USD | -4036.435% |
| BioVie Inc. | -32.12 Million USD | -1715.649% |
| Codexis, Inc. | -76.24 Million USD | -664.948% |
| Celularity Inc. | -196.29 Million USD | -197.102% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -171.849% |
| Celcuity Inc. | -63.77 Million USD | -814.4% |
| Virax Biolabs Group Limited | -6.73 Million USD | -8561.065% |
| Cibus, Inc. | -267.62 Million USD | -117.914% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1346.203% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1528.539% |
| IN8bio, Inc. | -30 Million USD | -1843.533% |
| Kodiak Sciences Inc. | -260.49 Million USD | -123.883% |
| Annexon, Inc. | -134.23 Million USD | -334.452% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -397.756% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -852.499% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1748.833% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -59.219% |
| Eyenovia, Inc. | -27.26 Million USD | -2039.298% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2801.107% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -108908.598% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -663.306% |
| Arcellx, Inc. | -70.69 Million USD | -725.005% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1307.292% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -335.819% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1841.592% |
| Moolec Science SA | -51.78 Million USD | -1026.103% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1013.586% |
| Geron Corporation | -184.12 Million USD | -216.736% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1289.422% |
| Royalty Pharma plc | 1.13 Billion USD | 151.39% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -328.959% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6458.805% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2645.326% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -239.719% |
| Humacyte, Inc. | -110.77 Million USD | -426.464% |
| Structure Therapeutics Inc. | -89.62 Million USD | -550.743% |
| 89bio, Inc. | -142.18 Million USD | -310.155% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -745.702% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5520.083% |
| Genelux Corporation | -28.29 Million USD | -1960.982% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1906.523% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -229.268% |
| Notable Labs, Ltd. | -11.26 Million USD | -5077.521% |
| Liquidia Corporation | -78.5 Million USD | -642.906% |
| Mustang Bio, Inc. | -51.6 Million USD | -1030.181% |
| Immunovant, Inc. | -259.33 Million USD | -124.88% |
| Quantum-Si incorporated | -95.96 Million USD | -507.749% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -700.555% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2909.112% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -507.559% |
| Acasti Pharma Inc. | -12.85 Million USD | -4437.431% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2496.846% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3553.731% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -219.747% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -13457.915% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4576.792% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1877.539% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1395.835% |
| PepGen Inc. | -78.62 Million USD | -641.734% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1859.072% |
| United Therapeutics Corporation | 984.8 Million USD | 159.22% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2519.928% |
| Solid Biosciences Inc. | -96.01 Million USD | -507.401% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12071.557% |
| Immuneering Corporation | -53.47 Million USD | -990.665% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11364.373% |
| Silo Pharma, Inc. | -3.7 Million USD | -15659.145% |
| Belite Bio, Inc | -31.63 Million USD | -1743.69% |
| XOMA Corporation | -40.83 Million USD | -1328.317% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -972.742% |
| Bionomics Limited | -15.49 Billion USD | 96.236% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -594.405% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1900.192% |
| uniQure N.V. | -308.47 Million USD | -89.056% |
| Cassava Sciences, Inc. | -97.21 Million USD | -499.891% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7876.177% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -372.491% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1752.828% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7010.67% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1906.316% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -108908.598% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2123.224% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3437.737% |
| Altimmune, Inc. | -88.44 Million USD | -559.373% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -284.735% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1900.192% |
| Compugen Ltd. | -18.75 Million USD | -3009.715% |
| Peak Bio, Inc. | -1259.26 USD | -46312496.287% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1166.468% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2581.238% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -72.141% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -603.035% |
| Zura Bio Limited | -60.36 Million USD | -866.196% |
| PolyPid Ltd. | -23.86 Million USD | -2343.729% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3607.068% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -603.035% |
| Instil Bio, Inc. | -156.08 Million USD | -273.635% |
| argenx SE | -295.05 Million USD | -97.658% |
| Immunome, Inc. | -106.8 Million USD | -446.033% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1272.42% |
| Verona Pharma plc | -54.36 Million USD | -972.663% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -483.68% |
| Shattuck Labs, Inc. | -87.29 Million USD | -568.052% |
| CervoMed Inc. | -2.17 Million USD | -26752.215% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -367.863% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4279.664% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1238.987% |
| Moolec Science SA | -51.78 Million USD | -1026.103% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3372587.406% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -331.622% |
| AnaptysBio, Inc. | -163.61 Million USD | -256.435% |
| Design Therapeutics, Inc. | -66.86 Million USD | -772.238% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -616.334% |
| NeurAxis, Inc. | -14.62 Million USD | -3887.206% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1439.507% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1613.569% |
| Achilles Therapeutics plc | -69.66 Million USD | -737.143% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -483.68% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2825.471% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 19483.074% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -22994502.225% |
| Nutriband Inc. | -5.48 Million USD | -10531.953% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -479.159% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1099.819% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -656.503% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1616.797% |
| MoonLake Immunotherapeutics | -36 Million USD | -1519.662% |
| Palisade Bio, Inc. | -12.3 Million USD | -4641.431% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1284.474% |
| Beam Therapeutics Inc. | -132.52 Million USD | -340.058% |
| Neurogene Inc. | -36.31 Million USD | -1505.849% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -256.88% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1009.666% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -494.207% |
| Sesen Bio, Inc. | -19.88 Million USD | -2832.991% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -714.702% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4560.387% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -31.34% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -422.736% |
| Athira Pharma, Inc. | -117.67 Million USD | -395.612% |
| Vaccinex, Inc. | -20.25 Million USD | -2779.838% |
| HCW Biologics Inc. | -24.99 Million USD | -2233.318% |
| XOMA Corporation | -40.83 Million USD | -1328.317% |
| Nektar Therapeutics | -276.05 Million USD | -111.26% |
| Arvinas, Inc. | -367.3 Million USD | -58.779% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -866139.881% |
| Merus N.V. | -154.93 Million USD | -276.404% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -498.592% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1758.2% |
| Rezolute, Inc. | -68.45 Million USD | -751.891% |
| Clene Inc. | -49.5 Million USD | -1078.079% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3681.224% |
| BeyondSpring Inc. | -21.02 Million USD | -2673.69% |
| Synlogic, Inc. | -57.28 Million USD | -918.114% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4800.395% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5286.994% |
| Peak Bio, Inc. | -1259.26 USD | -46312496.287% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1460.683% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5434.76% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -307.547% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -79.388% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -12526.119% |
| MannKind Corporation | -11.93 Million USD | -4785.207% |
| Ikena Oncology, Inc. | -68.16 Million USD | -755.553% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2675.142% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -527.545% |
| Gossamer Bio, Inc. | -179.81 Million USD | -224.328% |
| CohBar, Inc. | -11.96 Million USD | -4775.357% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2161.501% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1834.315% |
| Legend Biotech Corporation | -518.25 Million USD | -12.531% |
| Mural Oncology plc | -207.44 Million USD | -181.13% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -369.884% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3088.654% |
| Disc Medicine, Inc. | -76.42 Million USD | -663.056% |
| Champions Oncology, Inc. | -7.27 Million USD | -7915.338% |
| REGENXBIO Inc. | -263.49 Million USD | -121.332% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5395.071% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1127.652% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1435.393% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -482.247% |
| Vaxart, Inc. | -82.46 Million USD | -607.204% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 174833.568% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1453.428% |
| Cellectis S.A. | -101.05 Million USD | -477.085% |
| Longeveron Inc. | -21.41 Million USD | -2623.56% |
| Repare Therapeutics Inc. | -93.79 Million USD | -521.771% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -8.81% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -719.452% |
| Revolution Medicines, Inc. | -436.36 Million USD | -33.648% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -8775.301% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1792.019% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -741.152% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -800.939% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5844.307% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 116.112% |
| Denali Therapeutics Inc. | -145.22 Million USD | -301.584% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -484870.147% |
| Veru Inc. | -93.15 Million USD | -526.065% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2057.668% |
| Cingulate Inc. | -23.53 Million USD | -2378.0% |
| Passage Bio, Inc. | -102.06 Million USD | -471.413% |
| Context Therapeutics Inc. | -23.96 Million USD | -2333.612% |
| Exicure, Inc. | -16.91 Million USD | -3348.008% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -208.705% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1444.317% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -8862.147% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -215.791% |
| Nuvalent, Inc. | -126.21 Million USD | -362.051% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5445.978% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -571.274% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1809.364% |
| OmniAb, Inc. | -50.61 Million USD | -1052.129% |
| Anew Medical, Inc. | 1.34 Million USD | 43424.06% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3534.752% |
| Lipocine Inc. | -16.35 Million USD | -3466.494% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -778.387% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -815.895% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1282.185% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1115.828% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2840.83% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -7.702% |
| Ocugen, Inc. | -63.07 Million USD | -824.563% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -509.197% |
| Q32 Bio Inc. | -112.96 Million USD | -416.281% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3292.252% |
| Alumis Inc. Common Stock | -154.99 Million USD | -276.272% |
| Equillium, Inc. | -13.33 Million USD | -4273.423% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -866.1% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7201.051% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2993.677% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -887.096% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -409.221% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3073.346% |
| Dominari Holdings Inc. | -22.88 Million USD | -2448.711% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6864.021% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2779.98% |
| Bio-Techne Corporation | 168.1 Million USD | 446.924% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -65.639% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 552.606% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -378.689% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1437.194% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -417.743% |
| Nkarta, Inc. | -117.5 Million USD | -396.333% |
| BioCardia, Inc. | -11.57 Million USD | -4940.152% |
| Iterum Therapeutics plc | -38.37 Million USD | -1419.887% |